{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T04:52:31Z","timestamp":1764305551539},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11920-018-0880-4","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T03:34:34Z","timestamp":1521084874000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cannabinoid Receptors, Mental Pain and Suicidal Behavior: a Systematic Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Laura","family":"Colino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Herranz-Herrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Gil-Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ponte-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"del Sol-Calderon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rodrigo-Yanguas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Gil-Ligero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio J.","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilario","family":"Blasco-Fontecilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"880_CR1","unstructured":"WHO: Figures and facts about suicide. Geneva: World Health Organization; 1999."},{"issue":"7","key":"880_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.56.7.617","volume":"56","author":"RC Kessler","year":"1999","unstructured":"Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the national comorbidity survey. Arch Gen Psychiatry. 1999;56(7):617\u201326. \n                      https:\/\/doi.org\/10.1001\/archpsyc.56.7.617\n                      \n                    .","journal-title":"Arch Gen Psychiatry"},{"key":"880_CR3","unstructured":"WHO: Preventing suicide: a global imperative. Geneva: World Health Organization; 2014."},{"key":"880_CR4","first-page":"w13648","volume":"142","author":"S Czernin","year":"2012","unstructured":"Czernin S, Vogel M, Fluckiger M, Muheim F, Bourgnon JC, Reichelt M, et al. Cost of attempted suicide: a retrospective study of extent and associated factors. Swiss Med Wkly. 2012;142:w13648.","journal-title":"Swiss Med Wkly"},{"issue":"1-3","key":"880_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jad.2012.04.041","volume":"143","author":"X Gonda","year":"2012","unstructured":"Gonda X, Pompili M, Serafini G, Montebovi F, Campi S, Dome P, et al. Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors. J Affect Disord. 2012;143(1-3):16\u201326. \n                      https:\/\/doi.org\/10.1016\/j.jad.2012.04.041\n                      \n                    .","journal-title":"J Affect Disord"},{"key":"880_CR6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.12659\/MSM.890884","volume":"20","author":"B Ainiyet","year":"2014","unstructured":"Ainiyet B, Rybakowski JK. Suicidal behavior in schizophrenia may be related to low lipid levels. Med Sci Monit. 2014;20:1486\u201390. \n                      https:\/\/doi.org\/10.12659\/MSM.890884\n                      \n                    .","journal-title":"Med Sci Monit"},{"issue":"2","key":"880_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/sltb.12059","volume":"44","author":"M Amore","year":"2014","unstructured":"Amore M, Innamorati M, Vittorio CD, Weinberg I, Turecki G, Sher L, et al. Suicide attempts in major depressed patients with personality disorder. Suicide Life Threat Behav. 2014;44(2):155\u201366. \n                      https:\/\/doi.org\/10.1111\/sltb.12059\n                      \n                    .","journal-title":"Suicide Life Threat Behav."},{"issue":"3 Suppl 2","key":"880_CR8","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.amepre.2014.06.007","volume":"47","author":"KR Conner","year":"2014","unstructured":"Conner KR, Bagge CL, Goldston DB, Ilgen MA. Alcohol and suicidal behavior: what is known and what can be done. Am J Prev Med. 2014;47(3 Suppl 2):S204\u20138. \n                      https:\/\/doi.org\/10.1016\/j.amepre.2014.06.007\n                      \n                    .","journal-title":"Am J Prev Med"},{"issue":"9","key":"880_CR9","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.2105\/AJPH.2013.301422","volume":"103","author":"MS Kaplan","year":"2013","unstructured":"Kaplan MS, Giesbrecht N, Caetano R, Conner KR, Huguet N, McFarland BH, et al. Acute alcohol consumption as a contributing factor to suicidal behavior. Am J Public Health. 2013;103(9):e2\u20133. \n                      https:\/\/doi.org\/10.2105\/AJPH.2013.301422\n                      \n                    .","journal-title":"Am J Public Health"},{"issue":"4","key":"880_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/13811118.2016.1158678","volume":"20","author":"T Norstrom","year":"2016","unstructured":"Norstrom T, Rossow I. Alcohol consumption as a risk factor for suicidal behavior: a systematic review of associations at the individual and at the population level. Arch Suicide Res. 2016;20(4):489\u2013506. \n                      https:\/\/doi.org\/10.1080\/13811118.2016.1158678\n                      \n                    .","journal-title":"Arch Suicide Res."},{"issue":"10","key":"880_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tips.2006.08.006","volume":"27","author":"KY Vinod","year":"2006","unstructured":"Vinod KY, Hungund BL. Role of the endocannabinoid system in depression and suicide. Trends Pharmacol Sci. 2006;27(10):539\u201345. \n                      https:\/\/doi.org\/10.1016\/j.tips.2006.08.006\n                      \n                    .","journal-title":"Trends Pharmacol Sci"},{"key":"880_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000438510","volume":"84","author":"J Leon de","year":"2015","unstructured":"\u2022 de Leon J, Baca-Garcia E, Blasco-Fontecilla H. From the serotonin model of suicide to a mental pain model of suicide. Psychother Psychosom. 2015;84:323\u20139. This editorial criticizes the current, serotonin-based biological model of SB, by suggesting that mental pain is what really unifies SB.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"880_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.phrs.2010.01.002","volume":"61","author":"P Monteleone","year":"2010","unstructured":"Monteleone P, Bifulco M, Maina G, Tortorella A, Gazzerro P, Proto MC, et al. Investigation of cnr1 and faah endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol Res. 2010;61(5):400\u20134. \n                      https:\/\/doi.org\/10.1016\/j.phrs.2010.01.002\n                      \n                    .","journal-title":"Pharmacol Res"},{"issue":"4","key":"880_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 2011;124(4):250\u201361. \n                      https:\/\/doi.org\/10.1111\/j.1600-0447.2011.01687.x\n                      \n                    .","journal-title":"Acta Psychiatr Scand"},{"key":"880_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pain.2012.11.007","volume":"154","author":"F Benedetti","year":"2013","unstructured":"\u2022\u2022 Benedetti F, Thoen W, Blanchard C, Vighetti S, Arduino C. Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems. Pain. 2013;154:361\u20137. This article suggests that the meaning of pain can be changed using positive instructions, and the increased pain tolerance is mediated by the co-activation of the opioid and cannabinoid systems.","journal-title":"Pain"},{"issue":"Suppl 1","key":"880_CR16","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/sj.ijo.0803271","volume":"30","author":"I Matias","year":"2006","unstructured":"Matias I, Bisogno T, Di Marzo V. Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int J Obes. 2006;30(Suppl 1):S7\u2013S12.","journal-title":"Int J Obes"},{"key":"880_CR17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0090-6980(02)00060-6","volume":"68-69","author":"AC Howlett","year":"2002","unstructured":"Howlett AC. The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002;68-69:619\u201331. \n                      https:\/\/doi.org\/10.1016\/S0090-6980(02)00060-6\n                      \n                    .","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"880_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5455\/bcp.20120404074246","volume":"22","author":"MKM Yildiz","year":"2012","unstructured":"Yildiz MKM, Bozdemir MN, Kara B, Goktekin MC, Gurbuz S, Ayranci M, et al. Parasuicidal patients in the emergency department and their relationship with cannabinoid gene polymorphism. Bull Clinical Psychopharmacol. 2012;22(2):177\u201383. \n                      https:\/\/doi.org\/10.5455\/bcp.20120404074246\n                      \n                    .","journal-title":"Bull Clinical Psychopharmacol"},{"key":"880_CR19","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/ajad.12273","volume":"24","author":"R Icick","year":"2015","unstructured":"\u2022 Icick R, Peoc'h K, Karsinti E, Ksouda K, Hajj A, Bloch V, et al. A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients. Am J Addict. 2015;24:613\u201320. This study suggests that some CNR1 polymorphism can be protective against major depressive disorder in methadone-maintained outpatients.","journal-title":"Am J Addict"},{"key":"880_CR20","doi-asserted-by":"publisher","DOI":"10.1201\/b12215-6","volume-title":"Role of the endocannabinoid system in the neurobiology of suicide","author":"KY Vinod","year":"2012","unstructured":"Vinod KY. In: Dwivedi Y, editor. Role of the endocannabinoid system in the neurobiology of suicide. Boca Raton (FL): Taylor & Francis; 2012."},{"issue":"1","key":"880_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s002109900147","volume":"361","author":"M Nakazi","year":"2000","unstructured":"Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Arch Pharmacol. 2000;361(1):19\u201324.","journal-title":"Arch Pharmacol"},{"issue":"1-2","key":"880_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0304-3940(93)90437-P","volume":"156","author":"P Mailleux","year":"1993","unstructured":"Mailleux P, Vanderhaeghen JJ. Glucocorticoid regulation of cannabinoid receptor messenger rna levels in the rat caudate-putamen. An in situ hybridization study. Neurosci Lett. 1993;156(1-2):51\u20133. \n                      https:\/\/doi.org\/10.1016\/0304-3940(93)90437-P\n                      \n                    .","journal-title":"Neurosci Lett"},{"issue":"1","key":"880_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1753-2000-2-33","volume":"2","author":"TD Muller","year":"2008","unstructured":"Muller TD, Reichwald K, Bronner G, Kirschner J, Nguyen TT, Scherag A, et al. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatry Ment Health. 2008;2(1):33. \n                      https:\/\/doi.org\/10.1186\/1753-2000-2-33\n                      \n                    .","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"880_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","volume":"80","author":"AC Howlett","year":"2017","unstructured":"Howlett AC, Abood ME. CB1 and CB2 receptor pharmacology. Adv Pharmacol. 2017;80:169\u2013206. \n                      https:\/\/doi.org\/10.1016\/bs.apha.2017.03.007\n                      \n                    .","journal-title":"Adv Pharmacol"},{"key":"880_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"MD Sickle Van","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329\u201332.","journal-title":"Science"},{"issue":"2","key":"880_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.mp.4001376","volume":"9","author":"BL Hungund","year":"2004","unstructured":"Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB, et al. Upregulation of CB1 receptors and agonist-stimulated [35s]gtpgammas binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry. 2004;9(2):184\u201390. \n                      https:\/\/doi.org\/10.1038\/sj.mp.4001376\n                      \n                    .","journal-title":"Mol Psychiatry"},{"issue":"51","key":"880_CR27","doi-asserted-by":"publisher","first-page":"18620","DOI":"10.1073\/pnas.0509591102","volume":"102","author":"G Gobbi","year":"2005","unstructured":"Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A. 2005;102(51):18620\u20135. \n                      https:\/\/doi.org\/10.1073\/pnas.0509591102\n                      \n                    .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"880_CR28","first-page":"217","volume":"59","author":"P Adamczyk","year":"2008","unstructured":"Adamczyk P, Golda A, AC MC, Filip M, Przegalinski E. Activation of endocannabinoid transmission induces antidepressant-like effects in rats. J Physiol Pharmacol. 2008;59:217\u201328.","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"880_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.euroneuro.2005.03.003","volume":"15","author":"MN Hill","year":"2005","unstructured":"Hill MN, Gorzalka BB. Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacol. 2005;15(6):593\u20139. \n                      https:\/\/doi.org\/10.1016\/j.euroneuro.2005.03.003\n                      \n                    .","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"880_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","volume":"159","author":"M Martin","year":"2002","unstructured":"Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology. 2002;159(4):379\u201387. \n                      https:\/\/doi.org\/10.1007\/s00213-001-0946-5\n                      \n                    .","journal-title":"Psychopharmacology"},{"issue":"9","key":"880_CR31","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tips.2009.06.006","volume":"30","author":"MN Hill","year":"2009","unstructured":"Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends Pharmacol Sci. 2009;30(9):484\u201393. \n                      https:\/\/doi.org\/10.1016\/j.tips.2009.06.006\n                      \n                    .","journal-title":"Trends Pharmacol Sci"},{"key":"880_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jad.2016.02.007","volume":"195","author":"G Borges","year":"2016","unstructured":"\u2022\u2022 Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016;195:63\u201374. This is a recent and comprehensive review on SB and cannabis use. \n                      https:\/\/doi.org\/10.1016\/j.jad.2016.02.007\n                      \n                    .","journal-title":"J Affect Disord"},{"issue":"1","key":"880_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1745-0179-3-25","volume":"3","author":"G Serra","year":"2007","unstructured":"Serra G, Fratta W. A possible role for the endocannabinoid system in the neurobiology of depression. Clin Pract Epidemiol Ment Health. 2007;3(1):25. \n                      https:\/\/doi.org\/10.1186\/1745-0179-3-25\n                      \n                    .","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"5","key":"880_CR34","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.biopsych.2004.11.033","volume":"57","author":"KY Vinod","year":"2005","unstructured":"Vinod KY, Arango V, Xie S, Kassir SA, Mann JJ, Cooper TB, et al. Elevated levels of endocannabinoids and CB1 receptor-mediated g-protein signaling in the prefrontal cortex of alcoholic suicide victims. Biol Psychiatry. 2005;57(5):480\u20136. \n                      https:\/\/doi.org\/10.1016\/j.biopsych.2004.11.033\n                      \n                    .","journal-title":"Biol Psychiatry"},{"issue":"9","key":"880_CR35","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jpsychires.2009.11.013","volume":"44","author":"KY Vinod","year":"2010","unstructured":"Vinod KY, Kassir SA, Hungund BL, Cooper TB, Mann JJ, Arango V. Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides. J Psychiatr Res. 2010;44(9):591\u20137. \n                      https:\/\/doi.org\/10.1016\/j.jpsychires.2009.11.013\n                      \n                    .","journal-title":"J Psychiatr Res"},{"issue":"4","key":"880_CR36","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/adb.12160","volume":"20","author":"AM Erdozain","year":"2015","unstructured":"Erdozain AM, Rubio M, Valdizan EM, Pazos A, Meana JJ, Fernandez-Ruiz J, et al. The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects. Addict Biol. 2015;20(4):773\u201383. \n                      https:\/\/doi.org\/10.1111\/adb.12160\n                      \n                    .","journal-title":"Addict Biol"},{"key":"880_CR37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1177\/0269881115599388","volume":"29","author":"AM Erdozain","year":"2015","unstructured":"\u2022 Erdozain AM, Rubio M, Meana JJ, Fernandez-Ruiz J, Callado LF. Altered CB1 receptor coupling to g-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects. J Psychopharmacol. 2015;29:1137\u201345. This study reported that CB\n                              \n                      1\n                     receptor hypofunctioning was found in the caudate nucleus of suicides, thus expanding the previous findings on the role of CB\n                              \n                      1\n                     receptor in the prefrontal cortex.","journal-title":"J Psychopharmacol"},{"issue":"2","key":"880_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00213-009-1608-2","volume":"206","author":"L Uriguen","year":"2009","unstructured":"Uriguen L, Garcia-Fuster MJ, Callado LF, Morentin B, La Harpe R, Casado V, et al. Immunodensity and mrna expression of a2a adenosine, d2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology. 2009;206(2):313\u201324. \n                      https:\/\/doi.org\/10.1007\/s00213-009-1608-2\n                      \n                    .","journal-title":"Psychopharmacology"},{"key":"880_CR39","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/S0924-977X(12)70234-1","volume":"22","author":"MS Garcia-Gutierrez","year":"2012","unstructured":"Garcia-Gutierrez MS, Navarrete F, Giner S, Manzanares J. Cannabinoid CB2 receptor gene expression alterations in the dorsolateral prefrontal cortex and amygdala of suicide victims. Eur Neuropsychopharmacol. 2012;22:S166. \n                      https:\/\/doi.org\/10.1016\/S0924-977X(12)70234-1\n                      \n                    .","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"880_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neulet.2005.12.008","volume":"397","author":"K Connell","year":"2006","unstructured":"Connell K, Bolton N, Olsen D, Piomelli D, Hohmann AG. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett. 2006;397(3):180\u20134. \n                      https:\/\/doi.org\/10.1016\/j.neulet.2005.12.008\n                      \n                    .","journal-title":"Neurosci Lett"},{"issue":"6","key":"880_CR41","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1152\/jn.00498.2006","volume":"96","author":"C Liu","year":"2006","unstructured":"Liu C, Walker JM. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain. J Neurophysiol. 2006;96(6):2984\u201394. \n                      https:\/\/doi.org\/10.1152\/jn.00498.2006\n                      \n                    .","journal-title":"J Neurophysiol"},{"key":"880_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.brainresbull.2015.03.005","volume":"114","author":"I Racz","year":"2015","unstructured":"\u2022 Racz I, Nent E, Erxlebe E, Zimmer A. CB1 receptors modulate affective behaviour induced by neuropathic pain. Brain Res Bull. 2015;114:42\u20138. This study demonstrates that CB\n                              \n                      1\n                     receptors modulate affective behaviour induced by neuropathic pain.","journal-title":"Brain Res Bull"},{"key":"880_CR43","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.neuropharm.2016.02.018","volume":"105","author":"HJ Lee","year":"2016","unstructured":"Lee HJ, Chang LY, Ho YC, Teng SF, Hwang LL, Mackie K, et al. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid\/ CB1 signaling in the mouse periaqueductal gray. Neuropharmacology. 2016;105:577\u201386. \n                      https:\/\/doi.org\/10.1016\/j.neuropharm.2016.02.018\n                      \n                    .","journal-title":"Neuropharmacology"},{"key":"880_CR44","doi-asserted-by":"publisher","first-page":"174480691664919","DOI":"10.1177\/1744806916649192","volume":"12","author":"LM Carey","year":"2016","unstructured":"Carey LM, Slivicki RA, Leishman E, Cornett B, Mackie K, Bradshaw H, et al. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase. Mol Pain. 2016;12:174480691664919. \n                      https:\/\/doi.org\/10.1177\/1744806916649192\n                      \n                    .","journal-title":"Mol Pain"},{"issue":"2","key":"880_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0024-3205(99)00229-5","volume":"65","author":"BN Zenor","year":"1999","unstructured":"Zenor BN, Weesner GD, Malven PV. Endocrine and other responses to acute administration of cannabinoid compounds to non-stressed male calves. Life Sci. 1999;65(2):125\u201333. \n                      https:\/\/doi.org\/10.1016\/S0024-3205(99)00229-5\n                      \n                    .","journal-title":"Life Sci"},{"issue":"Suppl","key":"880_CR46","first-page":"39","volume":"48","author":"JJ Mann","year":"1987","unstructured":"Mann JJ. Psychobiologic predictors of suicide. J Clin Psychiatry. 1987;48(Suppl):39\u201343.","journal-title":"J Clin Psychiatry"},{"key":"880_CR47","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrn1220","volume":"4","author":"JJ Mann","year":"2003","unstructured":"Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci. 2003;4:819\u201328.","journal-title":"Nat Rev Neurosci"},{"key":"880_CR48","doi-asserted-by":"crossref","unstructured":"\u2022 Sudol K, Mann JJ. Biomarkers of suicide attempt behavior: towards a biological model of risk. Curr Psychiatry Rep. 2017;19:31. This is a recent review on biomarkers of suicide attempts.","DOI":"10.1007\/s11920-017-0781-y"},{"key":"880_CR49","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11920-013-0424-x","volume":"15","author":"H Blasco-Fontecilla","year":"2013","unstructured":"Blasco-Fontecilla H, Lopez-Castroman J, Giner L, Baca-Garcia E, Oquendo MA. Predicting suicidal behavior: are we really that far along? Comment on \u201cDiscovery and validation of blood biomarkers for suicidality\u201d. Curr Psychiatry Rep. 2013;15:424.","journal-title":"Curr Psychiatry Rep"},{"issue":"9600","key":"880_CR50","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","volume":"370","author":"R Christensen","year":"2007","unstructured":"Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370(9600):1706\u201313. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(07)61721-8\n                      \n                    .","journal-title":"Lancet"},{"issue":"2","key":"880_CR51","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","volume":"31","author":"FA Moreira","year":"2009","unstructured":"Moreira FA, Crippa JA. The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr. 2009;31(2):145\u201353. \n                      https:\/\/doi.org\/10.1590\/S1516-44462009000200012\n                      \n                    .","journal-title":"Rev Bras Psiquiatr"},{"issue":"7045","key":"880_CR52","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/nature03658","volume":"435","author":"AG Hohmann","year":"2005","unstructured":"Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, et al. An endocannabinoid mechanism for stress-induced analgesia. Nature. 2005;435(7045):1108\u201312. \n                      https:\/\/doi.org\/10.1038\/nature03658\n                      \n                    .","journal-title":"Nature"},{"issue":"6","key":"880_CR53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1521\/pedi.2010.24.6.773","volume":"24","author":"H Blasco-Fontecilla","year":"2010","unstructured":"Blasco-Fontecilla H, Baca-Garcia E, Duberstein P, Perez-Rodriguez MM, Dervic K, Saiz-Ruiz J, et al. An exploratory study of the relationship between diverse life events and specific personality disorders in a sample of suicide attempters. J Personal Disord. 2010;24(6):773\u201384. \n                      https:\/\/doi.org\/10.1521\/pedi.2010.24.6.773\n                      \n                    .","journal-title":"J Personal Disord"},{"issue":"1","key":"880_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13811118.2012.640616","volume":"16","author":"H Blasco-Fontecilla","year":"2012","unstructured":"Blasco-Fontecilla H, Delgado-Gomez D, Legido-Gil T, de Leon J, Perez-Rodriguez MM, Baca-Garcia E. Can the Holmes-Rahe Social Readjustment Rating Scale (SRRS) be used as a suicide risk scale? An exploratory study. Arch Suicide Res. 2012;16(1):13\u201328. \n                      https:\/\/doi.org\/10.1080\/13811118.2012.640616\n                      \n                    .","journal-title":"Arch Suicide Res"},{"key":"880_CR55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1176\/appi.ajp.2015.15040535","volume":"173","author":"Y Yovell","year":"2016","unstructured":"\u2022 Yovell Y, Bar G, Mashiah M, Baruch Y, Briskman I, Asherov J, et al. Ultra-low-dose buprenorphine as a time-limited treatment for severe suicidal ideation: a randomized controlled trial. Am J Psychiatry. 2016;173:491\u20138. This study suggests that buprenorphine can be used as a treatment for SB.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"880_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1521\/suli.33.3.219.23219","volume":"33","author":"I Orbach","year":"2003","unstructured":"Orbach I, Mikulincer M, Sirota P, Gilboa-Schechtman E. Mental pain: a multidimensional operationalization and definition. Suicide Life Threat Behav. 2003;33(3):219\u201330. \n                      https:\/\/doi.org\/10.1521\/suli.33.3.219.23219\n                      \n                    .","journal-title":"Suicide Life Threat Behav"},{"key":"880_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11682-012-9179-y","volume":"7","author":"EL Meerwijk","year":"2013","unstructured":"\u2022\u2022 Meerwijk EL, Ford JM, Weiss SJ. Brain regions associated with psychological pain: implications for a neural network and its relationship to physical pain. Brain Imaging Behav. 2013;7:1\u201314. This is one of the first studies suggesting that the neural network of psychological and physical pain partially overlap.","journal-title":"Brain Imaging Behav"},{"key":"880_CR58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000369937","volume":"84","author":"H Blasco-Fontecilla","year":"2015","unstructured":"\u2022 Blasco-Fontecilla H, Baca-Garc\u00eda E, Courtet P, Garc\u00eda Nieto R, de Leon J. Horror vacui: emptiness might distinguish between major suicide repeaters and nonmajor suicide repeaters: a pilot study. Psychother Psychosom. 2015;84:117\u20139. This pilot study suggests that the chronic feeling of emptiness is one of the most relevant pathways leading to major repetition of SB.","journal-title":"Psychother Psychosom"},{"issue":"5","key":"880_CR59","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/15325024.2011.572044","volume":"16","author":"EL Meerwijk","year":"2011","unstructured":"Meerwijk EL, Weiss SJ. Toward a unifying definition of psychological pain. J Loss & Trauma. 2011;16(5):402\u201312. \n                      https:\/\/doi.org\/10.1080\/15325024.2011.572044\n                      \n                    .","journal-title":"J Loss & Trauma"},{"key":"880_CR60","doi-asserted-by":"publisher","unstructured":"Hauser W, Petzke F, Fitzcharles MA. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management -an overview of systematic reviews. Eur J Pain 2017; doi: \n                      https:\/\/doi.org\/10.1002\/ejp.1118\n                      \n                    .","DOI":"10.1002\/ejp.1118"},{"key":"880_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/TCRM.S1928","volume":"4","author":"EB Russo","year":"2008","unstructured":"Russo EB. Cannabinoids In the management of difficult to treat pain. Ther Clin Risk Manag. 2008;4:245\u201359.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"880_CR62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/pm\/pnv080","volume":"17","author":"M Russo","year":"2016","unstructured":"Russo M, Naro A, Leo A, Sessa E, D'Aleo G, Bramanti P, et al. Evaluating sativex(r) in neuropathic pain management: a clinical and neurophysiological assessment in multiple sclerosis. Pain Med. 2016;17(6):1145\u201354. \n                      https:\/\/doi.org\/10.1093\/pm\/pnv080\n                      \n                    .","journal-title":"Pain Med"},{"key":"880_CR63","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2147\/TCRM.S115014","volume":"12","author":"T Etges","year":"2016","unstructured":"Etges T, Karolia K, Grint T, Taylor A, Lauder H, Daka B, et al. An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray. Ther Clin Risk Manag. 2016;12:1667\u201375. \n                      https:\/\/doi.org\/10.2147\/TCRM.S115014\n                      \n                    .","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"880_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40199-015-0109-6","volume":"23","author":"M Russo","year":"2015","unstructured":"Russo M, Rifici C, Sessa E, D'Aleo G, Bramanti P, Calabro RS. Sativex-induced neurobehavioral effects: causal or concausal? A practical advice! Daru. 2015;23(1):25. \n                      https:\/\/doi.org\/10.1186\/s40199-015-0109-6\n                      \n                    .","journal-title":"Daru"},{"key":"880_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.20882\/adicciones.38","volume":"26","author":"H Blasco-Fontecilla","year":"2014","unstructured":"\u2022 Blasco-Fontecilla H, Artieda-Urrutia P, Berenguer-Elias N, Garcia-Vega JM, Fernandez-Rodriguez M, Rodriguez-Lomas C, et al. Are major repeater patients addicted to suicidal behavior? Adicciones. 2014;26:321\u201333. This study clinically demonstrates that major repeaters (subjects with 5 or more lifetime SBs) are addicted to SB.","journal-title":"Adicciones"},{"key":"880_CR66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fpsyt.2016.00008","volume":"7","author":"H Blasco-Fontecilla","year":"2016","unstructured":"Blasco-Fontecilla H, Fernandez-Fernandez R, Colino L, Fajardo L, Perteguer-Barrio R, de Leon J. The addictive model of self-harming (non-suicidal and suicidal) behavior. Front Psychiatry. 2016;7:8.","journal-title":"Front Psychiatry"},{"issue":"4","key":"880_CR67","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/10253890.2011.586753","volume":"14","author":"CJ Riebe","year":"2011","unstructured":"Riebe CJ, Wotjak CT. Endocannabinoids and stress. Stress. 2011;14(4):384\u201397. \n                      https:\/\/doi.org\/10.3109\/10253890.2011.586753\n                      \n                    .","journal-title":"Stress"},{"issue":"1","key":"880_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/0269881111408958","volume":"26","author":"S Ruehle","year":"2012","unstructured":"Ruehle S, Rey AA, Remmers F, Lutz B. The endocannabinoid system in anxiety, fear memory and habituation. J Psychopharmacol. 2012;26(1):23\u201339. \n                      https:\/\/doi.org\/10.1177\/0269881111408958\n                      \n                    .","journal-title":"J Psychopharmacol"},{"key":"880_CR69","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.smim.2014.04.001","volume":"26","author":"CJ Hillard","year":"2014","unstructured":"Hillard CJ. Stress regulates endocannabinoid- CB1 receptor signaling. Semin Immunol. 2014;26:380\u20138.","journal-title":"Semin Immunol"},{"issue":"1","key":"880_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1124\/mol.104.006353","volume":"67","author":"J Lo Verme","year":"2005","unstructured":"Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005;67(1):15\u20139. \n                      https:\/\/doi.org\/10.1124\/mol.104.006353\n                      \n                    .","journal-title":"Mol Pharmacol"},{"issue":"5941","key":"880_CR71","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1171870","volume":"325","author":"AJ Pernia-Andrade","year":"2009","unstructured":"Pernia-Andrade AJ, Kato A, Witschi R, Nyilas R, Katona I, Freund TF, et al. Spinal endocannabinoids and CB1 receptors mediate c-fiber-induced heterosynaptic pain sensitization. Science. 2009;325(5941):760\u20134. \n                      https:\/\/doi.org\/10.1126\/science.1171870\n                      \n                    .","journal-title":"Science"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-018-0880-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-018-0880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-018-0880-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T01:10:00Z","timestamp":1552612200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-018-0880-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1007\/s11920-018-0880-4","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"15 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Laura Colino, Javier Herranz-Herrer, Elena Gil-Benito, Teresa Ponte-Lopez, Pablo del Sol-Calderon, Maria Rodrigo-Yanguas, Mar\u00eda Gil-Ligero, Antonio J S\u00e1nchez-L\u00f3pez, and Jose de Leon declare no conflict of interest.In the last 24\u00a0months Hilario Blasco-Fontecilla received lecture fees from AB-Biotics, Praxis Pharmaceuticals, and Shire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"19"}}